PRE 14A

PRELIMINARY PROXY STATEMENT

Company: Allarity Therapeutics, Inc.
Filed: September 8, 2022
Period of Report: September 8, 2022
Accession Number: 0001213900-22-054862

View Document ↗ View on SEC.gov ↗